Tia L Bush Centessa Pharmaceuticals PLC (CNTA) insider trading activity

Tia L Bush is Chief Technology & Quality Ofc of Centessa Pharmaceuticals plc. Currently has a direct ownership of 141,196 shares of CNTA, which is worth approximately $2.39 Million. The most recent transaction as insider was on Dec 31, 2024, when has been sold 6,419 shares (Ordinary Shares) at a price of $16.35 per share, resulting in proceeds of $104,950. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 141K

10.2% 3M change

19.99% 12M change

Total Value Held $2.39 Million

Tia L Bush Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 31 2024	SELL Payment of exercise price or tax liability	$104,950 $16.35 p/Share	6,419 Reduced 4.35%	141,196 Ordinary Shares
Dec 17 2024	SELL Open market or private sale	$320,634 $18.0 p/Share	17,813 Reduced 10.77%	147,615 Ordinary Shares
Dec 17 2024	BUY Exercise of conversion of derivative security	$68,580 $3.85 p/Share	17,813 Added 9.72%	165,428 Ordinary Shares
Dec 16 2024	SELL Open market or private sale	$157,235 $16.36 p/Share	9,611 Reduced 6.11%	147,615 Ordinary Shares
Sep 30 2024	SELL Payment of exercise price or tax liability	$101,356 $15.79 p/Share	6,419 Reduced 3.92%	157,226 Ordinary Shares
Jun 30 2024	SELL Payment of exercise price or tax liability	$57,963 $9.03 p/Share	6,419 Reduced 3.77%	163,645 Ordinary Shares
Mar 31 2024	SELL Payment of exercise price or tax liability	$72,534 $11.3 p/Share	6,419 Reduced 3.64%	170,064 Ordinary Shares
Feb 01 2024	SELL Payment of exercise price or tax liability	$31,629 $8.19 p/Share	3,862 Reduced 2.14%	176,483 Ordinary Shares
Feb 01 2024	BUY Grant, award, or other acquisition	-	42,500 Added 19.07%	180,345 Ordinary Shares
Dec 31 2023	SELL Payment of exercise price or tax liability	$51,095 $7.96 p/Share	6,419 Reduced 4.45%	137,845 Ordinary Shares
Sep 30 2023	SELL Payment of exercise price or tax liability	$41,530 $6.47 p/Share	6,419 Reduced 4.26%	144,264 Ordinary Shares
Jun 30 2023	SELL Payment of exercise price or tax liability	$37,872 $5.9 p/Share	6,419 Reduced 4.09%	150,683 Ordinary Shares
Mar 31 2023	SELL Payment of exercise price or tax liability	$16,844 $3.9 p/Share	4,319 Reduced 2.68%	157,102 Ordinary Shares
Feb 01 2023	BUY Grant, award, or other acquisition	-	30,200 Added 15.76%	161,421 Ordinary Shares
Dec 31 2022	SELL Payment of exercise price or tax liability	$9,343 $3.1 p/Share	3,014 Reduced 2.15%	136,986 Ordinary Shares
Oct 03 2022	SELL Open market or private sale	$10,250 $3.95 p/Share	2,595 Reduced 1.88%	135,287 Ordinary Shares
Sep 30 2022	SELL Payment of exercise price or tax liability	$24,501 $4.25 p/Share	5,765 Reduced 4.12%	134,235 Ordinary Shares
Sep 30 2022	SELL Open market or private sale	$8,620 $4.07 p/Share	2,118 Reduced 1.51%	137,882 Ordinary Shares
Jul 01 2022	BUY Grant, award, or other acquisition	-	140,000 Added 50.0%	140,000 Ordinary Shares

TLB

Tia L Bush

Chief Technology & Quality Ofc

Cheshire, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Value

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA

Account